Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper(II)) has been used for decades in low-concentration topical cosmetics with a generally favorable tolerability record, but there is almost no published human adverse-event data especially for injectable or systemic research use
Numerous clinical trials focusing on amyloid-beta (A) and Tau proteins of AD within recent decades have been ineffective (Asher and Priefer, 2022)
These findings have led researchers to examine BPC-157 in experimental systems studying receptor regulation, fibroblast proliferation pathways, and cross-talk between peptide signaling and anabolic regulatory mechanisms
The content on this website is for informational and educational purposes only and should not be considered medical advice
